Let’s Win, the National Alliance for Hispanic Health, and the Basser Center for BRCA teamed up to present a webinar on BRCA mutations and pancreatic cancer. Researchers are testing a type of targeted therapy called a PARP inhibitor for cancers carrying the PALB2 mutation. Who should be screen ed for pancreatic cancer? Dr. Allyson Ocean explains how genetic mutations and family history factor into screening. Dr. Raymond Wadlow explains how earlier detection of high-risk people is key the PRECEDE trial’s